A leading provider of innovative customer health care services beneath the Arcadia HealthCare brand.

Arcadia Resources to meet institutional investors at Barrington Research Health care Conference Arcadia Assets, Inc. , a leading provider of innovative customer health care services beneath the Arcadia HealthCare brand, announced President and CEO Marvin R today. On Tuesday Richardson and CFO Matthew Middendorf will attend the Barrington Research Healthcare Conference, August 25. Arcadia will present its story to institutional investors in some one-on-one meetings. The Barrington Research Health care conference will be held at the Hyatt Regency in Chicago.The mix of the drug, Hycamtin, and cisplatin may be the first medications for women for whom medical procedures or radiation therapy is normally unlikely to be effective against cervical malignancy that’s incurable, recurrent or persistent and has spread to other organs, the Food and Drug Administration said. The FDA originally authorized Hycamtin in 1996 for treating ovarian tumor and in 1998 for small-cell lung malignancy. GlaxoSmithKline makes Hycamtin, called topotecan hydrochloride also. The drug treatment isn’t a treat, but can offer a life-prolonging choice for women. In scientific trials involving 293 ladies, sufferers who received cisplatin and Hycamtin survived a little more than nine months, about three months longer than those on cisplatin alone.

Other entries from category "immunology":

Random entries